WGRX News and Press, Wellgistics Health Inc.

Medical insurance eligibility and benefits verification (EBV) is a core health technology capability necessary for PharmacyChain™ to gain market adoption EBV services offering enabled with preferred pricing being made immediately available to providers, partners and the Wellgistics ...

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 2030 1 Proprietary Forzet formulation provides pharmacists, physicians and patients with unique solution for GLP-1 drugs' primary side effect Forzet targeting preservation of muscle while on GLP-1 agonist therapy t...

Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum /Besu and Corda (R3) selected as most suitable blockchain platforms to build PharmacyChain ™ U.S. prescription drugs market project to grow from $634 billion market to $883 billion by 2030 according to Grandview Research [1] ...

The global blockchain in healthcare market is projected to grow from $11 billion in 2024 to $214 billion by 2030, with annual growth rates expected to exceed 60% Ongoing PharmacyChain® technology build-out already involves key technology components necessary to enable Healthcare...

2026-02-18 08:05:02 ET More on Wellgistics Health Seeking Alpha’s Quant Rating on Wellgistics Health Financial information for Wellgistics Health Read the full article on Seeking Alpha For further details see: Wellgistics Health invests in mental h...

Previously announced partnership with Tollo Health subsidiary TolloCare adding telehealth service offering to drive Wellgistics Pharmacy prescription drug dispending of GLP-1 drugs and promote patient engagement via mental health AI software solution for compliance and to promote lifestyle change...

Tollo Health recently formed subsidiary TolloCare, LLC ('TolloCare') initially targeted to provide telehealth services for GLP-1 and Long COVID patients TolloCare has white-labeled telehealth capabilities via a telemedicine company with over 5,000 onboarded physicians nationwide to provide...

Wellgistics Health to leverage EinsteinRx™ AI pharmacy hub and PharmacyChain™ smart contracts to drive healthcare optimization for former NFL players that and rural communities Focus areas include mental health, weight loss, sleep apnea, cardiometabolic disease, pain manageme...

ATLANTIC CITY, NJ / ACCESS Newswire / January 23, 2026 / DealFlow Events today announced the growing list of companies scheduled to present and participate in one-on-one meetings with investors and analysts at the DealFlow Discovery Conference , taking place January 28-29, 2026 , at the Borg...

Feasibility assessment completed, PharmacyChain™ to leverage Datavault AI's edge network and quantum key encryption to improve data driven outcomes in $634 billion prescription drug market Quantum key encryption fortities pharmacies from quantum's pending encryption-busting im...